MRK

2025Q1BMO

Merck & Company Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-04-24 · Fiscal end 2025-03-31 · Features as of 2025-04-23

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.14
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.1%
IV front—
P/C full—
P/C front—
Features as of2025-04-23

Run-up

Close—
Ret 5d+0.4%
Ret 10d-0.3%
Ret 20d-10.4%
Ret 30d-16.9%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.22Beat
Estimated EPS2.14
Actual revenue
15.6B
Surprise %+3.7%
Beat / missBeat
Beat streak 42
Beat streak 82

Reaction

1-day stock reaction+2.0%
Implied vs actual

Implied 2.1%Actual 0.6%

Gap reaction-0.6%
Day result+1.4%
Next-day upYes
Realized / IV0.27×

Post tape

Post 5d+4.3%
Post 10d-2.7%
Post volume18.5M
Vol ×10d1.08×
Vol ×20d1.11×
Post range5.0%